
Oral azacitidine is a chemotherapy medicine used as continued treatment for certain adults with acute myeloid leukaemia who achieved remission after intensive chemotherapy. It helps maintain remission and delay recurrence when further intensive curative treatment cannot be completed.
| Generic Name | Azacitidine |
| Strength | 300 mg |
| Manufacturer | Hetero |
| Packing | 14 Tablets |
| Prescribed For | Blood cancer and treatment of myelodysplastic syndrome |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Azacitidine becomes incorporated into the RNA and DNA of abnormal blood cells. It changes gene activity and interferes with the production of new genetic material. These effects can restore more normal cell behaviour and reduce the growth of leukaemia cells.
Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.